FTC Moves to Block Amgen Acquisition of Horizon Therapeutics
- May 19, 2023
The Federal Trade Commission (FTC) filed May 16 a lawsuit seeking to block Amgen Inc. from acquiring Horizon Therapeutics Plc, alleging the combination would stifle competition for drugs used to treat two serious conditions--thyroid eye disease and chronic refractory gout.
ARTICLE TAGS
You must be logged in to access this content.